Phentolamine clinical trials
Also written OraVerse.
How each study uses Phentolamine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Phentolamine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 30 Jan 1952 · REGITINE · NDA 008278 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
38 studies that test it; most in 2025 (6)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 6 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 18 · Other 20
Opus Genetics, Inc (13) · Novalar Pharmaceuticals, Inc. (4) · Radboud University Medical Center (2) · University of Alberta (2) · Dalhousie University (2) · University of Missouri-Columbia (2) · Vanderbilt University Medical Center (1) · sara nabil (1)
Often tested with
Tested in the same studies.
Propranolol (6) · Pilocarpine (3) · Phenylephrine (3) · Norepinephrine (3) · Isoproterenol (2) · Nitroprusside (1) · Alprostadil (1) · Papaverine (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 4, 1 in phase 3
Studies that test Phentolamine, phase 3 first.
- Aug 2027OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual AcuityPhase 3 · Opus Genetics, Inc
- Nov 2026Role of Sympathetic Vasoconstriction on Insulin-Mediated Microvascular Recruitment and Glucose Uptake in ObesityPhase 1 · Vanderbilt University Medical Center
- Dec 2026Sympathetic Vascular Transduction Across the Menopause Transition: Contributing MechanismsEarly Phase 1 · University of Missouri-Columbia
- Jul 2027Sex Disparities in Hypoxic Vasodilation and Impact of ObesityEarly Phase 1 · University of Missouri-Columbia
Studies
Open first, then newest update. How each study uses Phentolamine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 38
- OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual AcuityRecruitingPhase 3Opus Genetics, IncNCT07140783Written as 0.75% Phentolamine Ophthalmic Solution
- Sex Disparities in Hypoxic Vasodilation and Impact of ObesityRecruitingEarly Phase 1University of Missouri-ColumbiaNCT05219799Written as Phentolamine Mesylate
- Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex DifferencesRecruitingPhase 4University of AlbertaNCT05997732Written as Phentolamine Mesylate
- Sympathetic Vascular Transduction Across the Menopause Transition: Contributing MechanismsRecruitingEarly Phase 1University of Missouri-ColumbiaNCT06787066Written as Phentolamine Injection
- Effectiveness of Phentolamine Mesylate as a Reversing Agent for Local Anesthesia in ChildrenRecruitingPhase 3Cairo UniversityNCT05448807Written as OraVerse
- Adjusted Study Protocol: Within-Subject Paired-Eye Design Comparing Pilocarpine 0.1%, Phentolamine 0.75%, and Combination Therapy for Cyclopentolate Reversal in ChildrenNot yet recruitingNot applicableMansoura UniversityNCT07012512Written as Combination of pilocarpine 0.1% and phentolamine 0.75%
- Pre-operative Phentolamine Vs Intraoperative Esmolol Efficacy for Hypotensive Anesthesia in Functional Endoscopic Sinus SurgeryNot yet recruitingNot applicableAin Shams UniversityNCT06620991Written as Phentolamine
- Intravenous Labetalol vs Phentolamine for the Management of Severe Preeclampsia.Not yet recruitingNot applicableAssiut UniversityNCT06385600Written as Phentolamine
- Efficacy of Phentolamine in Prevention of Contrast-Associated Acute Kidney Injury After Complex PCIRecruitingPhase 2/3Helwan UniversityNCT06286059Written as Phentolamine
- New Perspective on Exploring the Post-apneic BP Surge in Patients With OSARecruitingEarly Phase 1Xu JNCT06172998Written as Phentolamine Injection
- Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis (MIRA-3)CompletedPhase 3Opus Genetics, IncNCT05134974Written as Phentolamine Ophthalmic Solution 0.75%
- Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) in Subjects With Dim Light Vision DisturbancesCompletedPhase 3Opus Genetics, IncNCT04638660Written as Phentolamine Ophthalmic Solution 0.75%
- Safety and Efficacy of Ophthalmic Phentolamine Mesylate to Reverse Pharmacologically Induced MydriasisCompletedPhase 2Opus Genetics, IncNCT04024891Written as Phentolamine Mesylate Ophthalmic Solution 1%
- Safety and Efficacy of Ophthalmic Phentolamine Mesylate in GlaucomaCompletedPhase 2Opus Genetics, IncNCT03960866Written as Phentolamine Mesylate Ophthalmic Solution 1%
- Safety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With PresbyopiaCompletedPhase 3Opus Genetics, IncNCT05646719Written as Phentolamine Opthalmic Solution 0.75%
- Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced MydriasisCompletedPhase 3Opus Genetics, IncNCT04620213Written as Phentolamine Ophthalmic Solution 0.75%
- The Safety and Efficacy of Phentolamine Mesylate Ophthalmic Solution in Subjects With Severe Night Vision DisturbancesCompletedPhase 2Opus Genetics, IncNCT01703559Written as Phentolamine Mesylate Ophthalmic Solution 1.0%
- Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With PresbyopiaCompletedPhase 2Opus Genetics, IncNCT04675151Written as Phentolamine Ophthalmic Solution 0.75%
- Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Pediatric SubjectsCompletedPhase 3Opus Genetics, IncNCT05223478Written as Phentolamine Ophthalmic Solution 0.75%
- Single Dose Study of Phentolamine Mesylate Eye Drops in Patients With Severe Night Vision DisturbancesCompletedPhase 2Opus Genetics, IncNCT04004507Written as Phentolamine Mesylate Ophthalmic Solution 1%
See all 38 studies that test Phentolamine →
Given beside what is tested · 1 — Phentolamine is usual care or a partner of the new treatment
Codes
What other systems call Phentolamine · ClinicalTrials.gg INT007999
- MeSH (NLM) D010646PhentolamineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) Z468598HBVPHENTOLAMINEConfirmed FDA, NLM, Wikidata
- RxNorm 8153Confirmed FDA, Wikidata
- Wikidata Q420360phentolamineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C62066PhentolamineOne source FDA
- DrugBank DB00692One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D010646 | Phentolamine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | Z468598HBV | PHENTOLAMINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 8153 | — | Confirmed FDA, Wikidata |
| Wikidata | Q420360 | phentolamine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C62066 | Phentolamine | One source FDA |
| DrugBank | DB00692 | — | One source Wikidata |
Also registered as phentolamine mesylate (UNII Y7543E5K9T · RxNorm 227240).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.